Cytokinetics prices $760M public offering of 11.34M shares at $71/sh

CYTOKINETICS INC

Offering of 9,859,155 shares at $71.00 per share; underwriters' option for 1,478,873 shares exercised in full.
Net proceeds of approximately $760.2 million after underwriting discounts and expenses.
Underwriters include Morgan Stanley, Goldman Sachs, J.P. Morgan, and Jefferies.
Offering made under automatic shelf registration statement filed February 27, 2025.
Prospectus supplement dated May 6, 2026 filed with SEC on May 7, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.